DORC
Entry
2019
Hold
5yr
Exit
2024
Who owns DORC?
DORC is a Dutch MedTech company, now owned by Carl Zeiss Meditec AG, which acquired it in 2024 from Eurazeo.
Hand-verified · updated 2026-09-30
Open JSON · CC-BYKey takeaways
- ·Fully exited in 2024 to Carl Zeiss Meditec AG.
- ·Best return: 2.6x MOIC by Eurazeo (2024 exit).
Exit Type
Trade Sale
Buyer
Carl Zeiss Meditec AG
MOIC
2.6x
Exit Year
2024
More from Eurazeo Capital IV
Other portfolio companies in the same fund.
Planet
Active
Fintech
UK· 2020
Questel
Active
SaaS
France· 2020
Elemica Inc
Active
Logistics
US· 2019
Albingia
2.2xExited 2025
Financials
France· 2018
to La Financiere de Blacailloux (Fiblac) consortium
Carambar & Co
1.5xExited 2025
Consumer
France· 2017
to Ferrara (Ferrero)
Iberchem
2.1xExited 2020
Industrials
Spain· 2017
to Croda International
More PE-backed in MedTech
Comparable medtech deals from other GPs.
Questions
Who owns DORC?
DORC is now owned by Carl Zeiss Meditec AG, which acquired it in 2024 from Eurazeo.
When did Carl Zeiss Meditec AG acquire DORC?
Carl Zeiss Meditec AG acquired DORC in 2024, buying from Eurazeo.
Who did DORC sell to?
Eurazeo sold DORC to Carl Zeiss Meditec AG in 2024 (Trade Sale), 2.6x return.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue